CVS Health shares rallied over the S&P 500 Index, and Goldman Sachs maintained a Buy rating on the stock.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CVS Health shares rallied over the S&P 500 Index, and Goldman Sachs maintained a Buy rating on the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Goldman Sachs
American investment bank
Related events
- HSBC restated its 'hold' rating on CVS Health, while Manufacturers Life Insurance Company increased its stake in the company's shares.
- Larry Robbins sold CVS Health shares, and Fifth Third Bancorp lifted its position in CVS Health stock, both disclosed to the SEC.
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
- CVS Health and Invesco were identified as top dividend stocks in a 2025 index.